Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

A novel CRISPR defense mechanism, unlike known nucleases, specifically destroys transfer ribonucleic acids (tRNA) that are ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

A live webcast of the presentation will be available on the "Events & Presentations" page in the Investors section of the ...

A sweeping genetic screen reveals how the brain is built and exposes a hidden gene behind a newly discovered childhood brain ...

Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In ...

BofA analyst Alec Stranahan lowered the firm’s price target on Crispr Therapeutics (CRSP) to $90 from $93 and keeps a Buy rating on the shares.

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...